1. Enhancing Therapeutic Approaches for Melanoma Patients Targeting Epigenetic Modifiers
   Maria Gracia-Hernandez et al, 2021, Cancers CrossRef
2. Mechanisms of Acquired BRAF Inhibitor Resistance in Melanoma: A Systematic Review
   Ilaria Proietti et al, 2020, Cancers CrossRef
3. Discovery of BRAF/HDAC Dual Inhibitors Suppressing Proliferation of Human Colorectal Cancer Cells
   Yingjun Li et al, 2022, Frontiers in Chemistry CrossRef
4. Characterization of Vemurafenib-Resistant Melanoma Cell Lines Reveals Novel Hallmarks of Targeted Therapy Resistance
   Martina Radić et al, 2022, International Journal of Molecular Sciences CrossRef
5. Correlation between Autophagy and Drug Resistance of Melanoma BRAF Inhibitors
   添 刘, 2022, Advances in Clinical Medicine CrossRef
6. The Histone Deacetylase Inhibitor ITF2357 (Givinostat) Targets Oncogenic BRAF in Melanoma Cells and Promotes a Switch from Pro-Survival Autophagy to Apoptosis
   Adriana Celesia et al, 2022, Biomedicines CrossRef
7. BRAF Gene and Melanoma: Back to the Future
   Margaret Ottaviano et al, 2021, International Journal of Molecular Sciences CrossRef
8. The mechanism and consequences of BRAF inhibitor resistance in melanoma
   Ksenia Golub et al, 2023, Genome Instability & Disease CrossRef